FDA Increased the Maximum Doses per Vial for Moderna COVID-19 Vaccine
April 02, 2021

In an April 1, 2021 statement, the FDA announced the authorization of a new multi-dose vial of Moderna's COVID-19 vaccine that contains up to 15 doses.

Pfizer-BioNTech COVID Vaccine Efficacy High at 6 Months, Companies Report
April 01, 2021

The COVID-19 vaccine partners announced an efficacy rate of >90% for BNT162b2 among 12 000 trial participants at up to 6 months after the second dose.

Pfizer-BioNTech COVID-19 Vaccine Found 100% Effective in Younger Teens
March 31, 2021

Pfizer-BioNTech announced today the complete protection against infection with SARS-CoV-2 among youth aged 12 to 15 years.